Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Lundbeck to acquire Prexton Therapeutics

Danish pharmaceutical company, Lundbeck, has agreed to acquire Prexton Therapeutics, PE Hub reported. Based in The Netherlands and in Switzerland, Prexton is a biopharmaceutical company. Prexton’s investors include Forbion, Seroba Life Sciences, Sunstone Capital and Ysios Capital.


Healthcare,M&A,M&A deals,mergers and acquisitions